Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...

The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.

NEW YORK — MRC Holland said on Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR ...

NEW YORK – Hologic officials said on Wednesday that M&A will be crucial to growing its business while expressing confidence that it has bolstered its skills at acquiring and integrating new assets.

Total revenues were $3.33 billion, up from $3.03 billion in the same quarter last year and slightly above the consensus Wall Street estimate of $3.31 billion.

The company said that growth in its diagnostics business was partly offset by declines in the Americas and China.

NEW YORK – Hologic said after the close of the market on Wednesday that its Diagnostics revenues jumped 5 percent year over year, driven by growth in the company's molecular diagnostics business, ...